These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6371141)

  • 1. A method using [3H]leucine-labeled granulocytes or macrophages for migration inhibition assay.
    Sandru G
    J Immunol Methods; 1984 Apr; 69(1):23-32. PubMed ID: 6371141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro migration inhibition of [3H]leucine-labeled granulocytes by supernatants of Con A-Sepharose stimulated MNC cultures.
    Sandru G; Veraguth P
    Immunol Lett; 1985; 10(3-4):127-32. PubMed ID: 3899921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An indirect assay for canine leukocyte migration inhibitory factor (LIF): demonstration of its species specificity.
    Ansfield MJ; Shalaby MR; Kaltreider HB
    J Immunol Methods; 1980; 34(1):43-8. PubMed ID: 6448271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The indirect assay for leukocyte migration inhibitory factor (LIF)--standardization and the effect of pH.
    Willoughby EW; Dupont B; Hansen JA; Good RA
    J Immunol Methods; 1978; 22(1-2):99-110. PubMed ID: 27562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by adherent cells and irradiation of in vitro LIF production by Con-A stimulated mononuclear cells.
    Sandru G; Veraguth P
    Immunobiology; 1981; 159(4-5):419-31. PubMed ID: 7026420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ELISA method for quantitation of macrophage migration from agarose microdroplets.
    Peck R
    J Immunol Methods; 1983 Nov; 64(1-2):179-87. PubMed ID: 6358361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of assay conditions for macrophage migration from an agarose droplet.
    Fahlbusch B; Dornberger G
    Acta Biol Med Ger; 1979; 38(10):1453-60. PubMed ID: 44954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between agarose microdroplet and capillary tube procedures as assays for migration inhibition of target cells.
    Adelman N; Hasson M; Masih N; Cohen MC
    J Immunol Methods; 1980; 34(3):235-42. PubMed ID: 6995527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical improvements in the clotted plasma droplet MIF assay in vitro.
    Sandru G; Veraguth P
    J Immunol Methods; 1979; 29(3):279-86. PubMed ID: 489994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of a complement-dependent migration inhibitory activity in normal guinea pig serum.
    Sandru G; Veraguth P
    Allergy; 1980 Jan; 35(1):37-43. PubMed ID: 6989284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-restricted effects of human and mouse lymphokines on macrophages.
    Tagliabue A; Mantovani A; Boraschi D; Herberman RB
    Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
    McCoy JL; Dean JH; Herberman RB
    J Immunol Methods; 1977; 15(4):355-71. PubMed ID: 874326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of human lymphoid cell line lymphokine preparations (LCL-LK) as working standards in the bioassay of human leucocyte migration inhibition factor (LIF).
    Hamblin AS; Zawisza B; Shipton U; Dumonde DC; Den Hollander FC; Verheul H
    J Immunol Methods; 1982 Nov; 54(3):317-29. PubMed ID: 6757327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Products of activated lymphocytes. I. The use of radiolabeling techniques in the characterization and partial purification of the migration inhibition factor of the guinea pig.
    Sorg C; Bloom BR
    J Exp Med; 1973 Jan; 137(1):148-70. PubMed ID: 4688317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte migration inhibition factor (LIF) increases polymorphonuclear cell endocytosis.
    Cortés-Castillo MA; Favila-Castillo L
    Arch Invest Med (Mex); 1991; 22(1):35-40. PubMed ID: 1819974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro assay of leukocyte migration inhibitory activity from human lymphocytes stimulated with concanavalin A.
    Bendtzen K; Andersen V; Bendixen G
    Acta Allergol; 1975 Jul; 30(2-3):133-49. PubMed ID: 1173991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors.
    Thurman GB; Stull HB; Miller PJ; Stevenson HC; Oldham RK
    J Immunol Methods; 1983 Dec; 65(1-2):41-53. PubMed ID: 6361142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucocyte migration inhibitory activity (LMIA) on concanavalin A (Con-A) stimulated human lymphocytes. Comparison of leucocyte migration capillary technique (LMCT), leucocyte migration agarose technique (LMAT), and leucocyte migration fibrinolysis technique (LMFT).
    Coeugniet E; Bendixen G
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):485-8. PubMed ID: 793298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo leucocytes migration agarose technique. A new and simple method for measuring the migration of tissue-pool granulocytes.
    Matusiewicz R; Brzezińska B
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):301-7. PubMed ID: 1810222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.